Enhanced survival of mice infused with bone marrow-derived as compared with adipose-derived mesenchymal stem cells

Hepatology Research

Volumn 45, Issue 13, 2015, Pages 1353-1359

  Shiratsuki, Shogo ^a   Terai, Shuji ^a   Murata, Yasuhiko ^a   Takami, Taro ^a   Yamamoto, Naoki ^a   Fujisawa, Koichi ^a   Burganova, Guzel ^a,b   Quintanilha, Luiz Fernando ^a,c   Sakaida, Isao ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Matrix metalloproteinase; Mesenchymal stem cell; Pro coagulation; Tissue factor

Indexed keywords

MESSENGER RNA; THROMBOPLASTIN;

ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CAUSE OF DEATH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; WESTERN BLOTTING;

EID: 84988306089     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12507     Document Type: Article

References (9)

1. Terai S, Ishikawa T, Omori K et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006; 24: 2292-8.
2. Terai S, Tanimoto H, Maeda M et al. Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy. J Gastroenterol 2012; 47: 491-7.
3. Takami T, Terai S, Sakaida I. Advanced therapies using autologous bone marrow cells for chronic liver disease. Discov Med 2012; 14: 7-12.
4. Takami T, Terai S, Sakaida I. Stem cell therapy in chronic liver disease. Curr Opin Gastroenterol 2012; 28: 203-8.
5. Banas A, Teratani T, Yamamoto Y et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 2007; 46: 219-28.
6. Tatsumi K, Ohashi K, Matsubara Y et al. Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism. Biochem Biophys Res Commun 2013; 431: 203-9.
7. Iwamoto T, Terai S, Hisanaga T et al. Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice. Cell Tissue Res 2013; 351: 487-95.
8. Tanimoto H, Terai S, Taro T et al. Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow. Cell Tissue Res 2013; 354: 717-28.
9. Terai S, Takami T, Yamamoto N et al. Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells. Tissue Eng Part B Rev 2014; 20: 206-10.